- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06364982
Distance Between Dental Implants as a Risk Indicator for Peri-implant Disease.
Distance Between Dental Implants as a Risk Indicator for Peri-implant Disease. A Multi-center Cross-sectional Study
Study Overview
Status
Conditions
Detailed Description
The present research project has been designed as a multicentric cross-sectional study. The STROBE guidelines have been followed in the design of this observational study.
Ethical issues The study will be performed after the approval of the Ethics Committee of the Universitat Internacional de Catalunya (UIC) and Faculdade de Medicina Dentária da Universidade de Lisboa (FMDUL) and will be intended to be registered in clinicaltrials.gov. Also, this research will be conducted according to the principles outlined in the Declaration of Helsinki (revised, amended, and clarified in 2013). In addition, all study participants will provide written informed consent before participating in the study.
Study population Subjects will be selected from an electronic database collected at the CUO (UIC) / CU (FMDUL) and composed of patients treated with at least two contiguous dental implants before 2021. This investigation will use a stratified random sampling based on year of implant placement to select a representative sample of subjects with implant-supported restorations conducted during the period 2001-2020 at the CUO and CU. Then, two examiners (I.T. / F.F.) will contact patients by telephone once every 2 days (with a maximum of 3 attempts) for an evaluation by the same investigators (I.T / F.F).
Criteria for subject selection will be as follows:
- The patient must be ≥18 years of age and systemically healthy;
- Partially edentulous patients, rehabilitated until 2020 (i.e., a minimum of 3 years of function time) with at least two contiguous implant-supported restorations in the maxilla or mandible;
- Screw or cemented-retained prosthesis;
- Fixed dental prosthesis (i.e., single crowns and partial prosthesis);
- No implant mobility.
Moreover, the exclusion criteria will be the following:
- Pregnant and lactating women;
- Patients who have taken systemic antibiotics during the 3 months prior to the examination;
- Patients being treated with drugs that may induce a gingival overgrowth;
- Patients undergoing orthodontic treatment (since it can influence periodontal diagnosis);
- Patients who have received mechanical debridement during the 3 months prior to the exam;
- Patients who have received surgical treatment for peri-implantitis;
- Psychophysical inability to carry out study procedures.
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Ioannis Terpou, MSc
- Phone Number: +306978218177
- Email: ioannisterpou.95@uic.es
Study Contact Backup
- Name: Tiago R Amaral, MSc
- Phone Number: +351916067069
- Email: tiagoamaral@edu.ulisboa.pt
Study Locations
-
-
Barcelona
-
Sant Cugat Del Vallès, Barcelona, Spain, 08195
- Clínica Universitaria de Odontologia
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- The patient must be ≥18 years of age and systemically healthy;
- Partially edentulous patients, rehabilitated until 2020 (i.e., a minimum of 3 years of function time) with at least two contiguous implant-supported restorations in the maxilla or mandible;
- Screw or cemented-retained prosthesis;
- Fixed dental prosthesis (i.e., single crowns and partial prosthesis);
- No implant mobility.
Exclusion Criteria:
- Pregnant and lactating women;
- Patients who have taken systemic antibiotics during the 3 months prior to the examination;
- Patients being treated with drugs that may induce a gingival overgrowth;
- Patients undergoing orthodontic treatment (since it can influence periodontal diagnosis);
- Patients who have received mechanical debridement during the 3 months prior to the exam;
- Patients who have received surgical treatment for peri-implantitis;
- Psychophysical inability to carry out study procedures.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Inter-implant distance ≤ 3mm
Presence of an inter-implant distance ≤ 3mm
|
Implant Placement of 2 contiguous dental implants with less ≤ 3mm from each other.
|
Inter-implant distance ≥ 3mm
Presence of an inter-implant distance ≥ 3mm
|
Implant Placement of 2 contiguous dental implants with > 3mm from each other.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Prevalence of peri-implant diseases.
Time Frame: At least 36 months of function - at the moment of the evaluation
|
Prevalence of peri-implant mucositis and peri-implantitis.
|
At least 36 months of function - at the moment of the evaluation
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
FMPI
Time Frame: At least 36 months of function - at the moment of the evaluation
|
Full Mouth Plaque Index
|
At least 36 months of function - at the moment of the evaluation
|
FMBI
Time Frame: At least 36 months of function - at the moment of the evaluation
|
Full Mouth Bleeding Index
|
At least 36 months of function - at the moment of the evaluation
|
mPI
Time Frame: At least 36 months of function - at the moment of the evaluation
|
modified Plaque Index
|
At least 36 months of function - at the moment of the evaluation
|
mBI
Time Frame: At least 36 months of function - at the moment of the evaluation
|
modified Bleeding Index
|
At least 36 months of function - at the moment of the evaluation
|
SoP
Time Frame: At least 36 months of function - at the moment of the evaluation
|
Suppuration on Probing
|
At least 36 months of function - at the moment of the evaluation
|
PPD
Time Frame: At least 36 months of function - at the moment of the evaluation
|
Probing Pocket Depth
|
At least 36 months of function - at the moment of the evaluation
|
MR
Time Frame: At least 36 months of function - at the moment of the evaluation
|
Mucosal Recession
|
At least 36 months of function - at the moment of the evaluation
|
KM
Time Frame: At least 36 months of function - at the moment of the evaluation
|
Keratinized Mucosa
|
At least 36 months of function - at the moment of the evaluation
|
Implant location
Time Frame: At least 36 months of function - at the moment of the evaluation
|
Implant location in the oral cavity
|
At least 36 months of function - at the moment of the evaluation
|
Implant position
Time Frame: At least 36 months of function - at the moment of the evaluation
|
Implant position in the oral cavity
|
At least 36 months of function - at the moment of the evaluation
|
Implant type
Time Frame: At least 36 months of function - at the moment of the evaluation
|
Implant type used
|
At least 36 months of function - at the moment of the evaluation
|
Implant brand
Time Frame: At least 36 months of function - at the moment of the evaluation
|
Brand of the implant used
|
At least 36 months of function - at the moment of the evaluation
|
Implant roughness
Time Frame: At least 36 months of function - at the moment of the evaluation
|
Type of implant roughness
|
At least 36 months of function - at the moment of the evaluation
|
Implant diameter
Time Frame: At least 36 months of function - at the moment of the evaluation
|
Type of implant diameter
|
At least 36 months of function - at the moment of the evaluation
|
Implant length
Time Frame: At least 36 months of function - at the moment of the evaluation
|
Length of the implant
|
At least 36 months of function - at the moment of the evaluation
|
Apico-coronal position of the implant
Time Frame: At least 36 months of function - at the moment of the evaluation
|
Apico-coroal position
|
At least 36 months of function - at the moment of the evaluation
|
Inter-implant distances (IID)
Time Frame: At least 36 months of function - at the moment of the evaluation
|
Inter-implant distance
|
At least 36 months of function - at the moment of the evaluation
|
Implant placement protocol
Time Frame: At least 36 months of function - at the moment of the evaluation
|
Moment of the implant placement
|
At least 36 months of function - at the moment of the evaluation
|
Bone grafting procedures (BGP) at implant placement
Time Frame: At least 36 months of function - at the moment of the evaluation
|
Bone grafting associated with the implant placement
|
At least 36 months of function - at the moment of the evaluation
|
Implant-supported restorations
Time Frame: At least 36 months of function - at the moment of the evaluation
|
Screwed or Cemented
|
At least 36 months of function - at the moment of the evaluation
|
Cleansability of the prosthesis
Time Frame: At least 36 months of function - at the moment of the evaluation
|
Cleansable, difficult or impossible to clean
|
At least 36 months of function - at the moment of the evaluation
|
Collaborators and Investigators
Investigators
- Study Director: Cristina V Vallès, PhD, Department of Periodontology, University Internacional de Cataluña
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- PER-ECL-2023-05
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Peri-Implantitis
-
PolyPid Ltd.MIS Implant Technologies, LtdCompleted
-
University of ManitobaUnknownPeri ImplantitisCanada
-
University of ValenciaCompletedEarly Apical Peri-implantitis
-
Rambam Health Care CampusRecruitingDental Implants,Peri-implantitis,SmokingIsrael
-
Tuğba ŞAHİNCompletedPeri-Implantitis, Peri-implant MucositisTurkey
-
Proed, Torino, ItalyCompleted
-
University of ZagrebNot yet recruitingPeri-implant Mucositis | Peri-Implantitis and Peri-implant Mucositis | Peri-implant Health | Periimplant Diseases | Periimplant Bone Loss
-
National and Kapodistrian University of AthensRecruitingPeri-Implantitis | Peri-Implant HealthGreece
-
Center of Implantology, Oral and Maxillofacial...Recruiting
-
University of BaghdadRecruiting